Central vein sign for multiple sclerosis: A systematic review and meta-analysis

Fog, 1964, On the vessel-plaque relationships in the brain in multiple sclerosis, Acta Neurol Scand Suppl, 40, 9, 10.1111/j.1600-0404.1964.tb04716.x Sati, 2016, The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative, Nat Rev Neurol, 12, 714, 10.1038/nrneurol.2016.166 Sinnecker, 2019, Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis, JAMA Neurol, 76, 10.1001/jamaneurol.2019.2478 Filippi, 2016, MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines, Lancet Neurol, 15, 292, 10.1016/S1474-4422(15)00393-2 Gobbin, 2019, 2017 McDonald criteria for multiple sclerosis: earlier diagnosis with reduced specificity?, Mult Scler Relat Disord, 29, 23, 10.1016/j.msard.2019.01.008 Habek, 2018, Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria, Mult Scler Relat Disord, 25, 99, 10.1016/j.msard.2018.07.035 Hyun, 2019, Application of the 2017 McDonald diagnostic criteria for multiple sclerosis in Korean patients with clinically isolated syndrome, Mult Scler, 25, 1488, 10.1177/1352458518790702 van der Vuurst de Vries, 2018, Application of the 2017 revised McDonald criteria for multiple sclerosis to patients with a typical clinically isolated syndrome, JAMA Neurol, 75, 1392, 10.1001/jamaneurol.2018.2160 Kollia, 2009, First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5 T and 7 T, AJNR Am J Neuroradiol, 30, 699, 10.3174/ajnr.A1434 Kuchling, 2014, Identical lesion morphology in primary progressive and relapsing-remitting MS—an ultrahigh field MRI study, Mult Scler, 20, 1866, 10.1177/1352458514531084 Tallantyre, 2009, A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions, Invest Radiol, 44, 491, 10.1097/RLI.0b013e3181b4c144 Mistry, 2016, Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions, Mult Scler, 22, 1289, 10.1177/1352458515616700 Sinnecker, 2012, Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis, Neurology, 79, 708, 10.1212/WNL.0b013e3182648bc8 Tallantyre, 2011, Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions, Neurology, 76, 534, 10.1212/WNL.0b013e31820b7630 Wuerfel, 2012, Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis, Mult Scler, 18, 1592, 10.1177/1352458512441270 Aliaga, 2014, MRI mimics of multiple sclerosis, Handb Clin Neurol, 122, 291, 10.1016/B978-0-444-52001-2.00012-1 Moher, 2015, Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement, Syst Rev, 4, 1, 10.1186/2046-4053-4-1 Thompson, 2018, Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria, Lancet Neurol, 17, 162, 10.1016/S1474-4422(17)30470-2 Darwish, 2018, Value of central vein sign in discriminating multiple sclerosis plaques from other white matter lesions, Egypt J Radiol Nucl Med, 49, 165, 10.1016/j.ejrnm.2017.12.008 Maggi, 2019, The "central vein sign" in patients with diagnostic "red flags" for multiple sclerosis: a prospective multicenter 3T study, Mult Scler Cortese, 2018, Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD, Neurology, 90, e1183, 10.1212/WNL.0000000000005256 Al-Zandi, 2018, Central vein sign detected by SWI at 3 T MRI as a discriminator between multiple sclerosis and leukoaraiosis, Egypt J Radiol Nucl Med, 49, 158, 10.1016/j.ejrnm.2017.09.003 Maggi, 2018, Central vein sign differentiates multiple sclerosis from central nervous system inflammatory vasculopathies, Ann Neurol, 83, 283, 10.1002/ana.25146 Clarke, 2015, Diagnosing multiple sclerosis using the central vein sign. What is the agreement between a blinded rater and the final diagnosis using T2*weighted sequences at 3T MRI?, Mult Scler J, 21, 483 Cortese, 2016, The central vein sign on SWI at 3T MRI differentiates multiple sclerosis from neuromyelitis optica, Neurology, 86, 4 Grammatico, 2017, Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis, Mult Scler J, 23, 432 Kau, 2013, The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?, Eur Radiol, 23, 1956, 10.1007/s00330-013-2791-4 Samaraweera, 2017, The central vein sign in multiple sclerosis lesions is present irrespective of the T2* sequence at 3 T, J Neuroimaging, 27, 114, 10.1111/jon.12367 Solomon, 2018, Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm, Mult Scler, 24, 750, 10.1177/1352458517726383 Dworkin, 2019, An automated probabilistic algorithm for the detection of central vein sign in white-matter lesions, Mult Scler J, 25, 16 Fartaria, 2019, CVSnet: a deep learning-based approach for automated detection of the central vein sign, Mult Scler J, 25, 16 Dworkin, 2018, Automated integration of multimodal MRI for the probabilistic detection of the central vein sign in white matter lesions, AJNR Am J Neuroradiol, 39, 1806, 10.3174/ajnr.A5765 Valcarcela, 2018, MIMoSA: an automated method for inter-modal segmentation analysis of multiple sclerosis brain lesions, J Neuroimaging, 28, 389, 10.1111/jon.12506 Reichenbach, 1997, Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent, Radiology, 204, 272, 10.1148/radiology.204.1.9205259